Skip to main content
. 2022 Jun 11;14(12):2885. doi: 10.3390/cancers14122885

Figure 7.

Figure 7

PapSEEK, proposed by Wang et al. [90], (A) DNA extracted from patient cytologic fluids and plasma is assayed for genetic alterations. (B) Target genes assayed for mutations were found in cytologic fluid for endometrial cancer samples and in both cytologic fluids and plasma for ovarian cancer samples but not in healthy controls. Used with permission.